On March 17, 2021, the U.S. Environmental Protection Agency (EPA) announced the issuance of the final guidance document entitled "Guidance for Waiving Acute Dermal Toxicity Tests for Pesticide ...

Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "Dermal Toxicity Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's ...

Please provide your email address to receive an email when new articles are posted on . ATR-04 is currently being developed to treat dermal toxicity from epidermal growth factor receptor inhibitor ...

On October 7, 2020, the U.S. Environmental Protection Agency (EPA) announced that it is requesting comments on its draft guidance that would allow registrants, in certain circumstances, to forgo ...

Azitra Inc. has obtained IND clearance from the FDA for a first-in-human phase I/II study of ATR-04 for moderate to severe EGFR inhibitor-associated dermal toxicity. The study is expected to begin by ...

Ratings corresponding to the following definitions are derived from data obtained from the test methods as described in 16 CFR 1500.41 and/or NAS Publication 1138, and categories of toxicity as ...

Toxicity-testing strategies designed to generate information on potential hazards or risks posed by environmental agents have evolved in response to legislative mandates, scientific developments, and ...